Stem cells for pancreatic &bgr;-cell replacement in diabetes mellitus: actual perspectives

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current Opinion in Organ Transplantation

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MOT.0000000000000055PMID 24553500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus.

  2013cited by this paper
• Hematopoietic stem cells are pluripotent and not just "hematopoietic".

  2013cited by this paper
• Concise Review: Pancreas Regeneration: Recent Advances and Perspectives

  2012cited by this paper
• From cellular therapies to tissue reprogramming and regenerative strategies in the treatment of diabetes.

  2012cited by this paper
• Improvement in Outcomes of Clinical Islet Transplantation: 1999–2010

  2012cited by this paper
• Immunogenicity and Immunomodulatory Properties of Umbilical Cord Lining Mesenchymal Stem Cells

  2011cited by this paper
• Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I

  2011cited by this paper
• Stem cell-based strategies for the treatment of type 1 diabetes mellitus

  2011cited by this paper
• HLA Genes, Islet Autoantibodies and Residual C-Peptide at the Clinical Onset of Type 1 Diabetes Mellitus and the Risk of Retinopathy 15 Years Later

  2011cited by this paper
• β-cell regeneration: the pancreatic intrinsic faculty.

  2011cited by this paper
• New Simple and Rapid Method for Purification of Mesenchymal Stem Cells from the Human Umbilical Cord Wharton Jelly

  2011cited by this paper
• Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

  2011cited by this paper
• Sox9+ ductal cells are multipotent progenitors throughout development but do not produce new endocrine cells in the normal or injured adult pancreas

  2011cited by this paper
• Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes

  2010cited by this paper
• Cellular plasticity within the pancreas--lessons learned from development.

  2010cited by this paper
• Genetics, pathogenesis and clinical interventions in type 1 diabetes

  2010cited by this paper
• Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study

  2010cited by this paper
• Human Induced Pluripotent Stem Cells Develop Teratoma More Efficiently and Faster Than Human Embryonic Stem Cells Regardless the Site of Injection

  2010cited by this paper
• Generation of pluripotent stem cells from patients with type 1 diabetes

  2009cited by this paper
• Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells

  2009cited by this paper
• Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

  2009cited by this paper
• Faculty Opinions recommendation of The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells.

  2009cited by this paper
• The Emerging Role of SOX Transcription Factors in Pancreatic Endocrine Cell Development and Function

  2009cited by this paper
• Morality and human embryo research

  2009cited by this paper
• Generation of Pancreatic Hormone‐Expressing Islet‐Like Cell Aggregates from Murine Adipose Tissue‐Derived Stem Cells

  2009cited by this paper
• Transcription factors involved in glucose-stimulated insulin secretion of pancreatic beta cells.

  2009cited by this paper
• The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells.

  2009cited by this paper
• Stem cell sources to treat diabetes

  2009cited by this paper
• Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers

  2009cited by this paper
• Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media.

  2009cited by this paper
• Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells.

  2008cited by this paper
• Immune Properties of Human Umbilical Cord Wharton's Jelly‐Derived Cells

  2008cited by this paper
• Pdx-1 and Ptf1a concurrently determine fate specification of pancreatic multipotent progenitor cells.

  2008cited by this paper
• Can β‐cells be derived from exocrine pancreas?

  2008cited by this paper
• Combined Islet and Hematopoietic Stem Cell Allotransplantation: A Clinical Pilot Trial to Induce Chimerism and Graft Tolerance

  2008cited by this paper
• β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans

  2008cited by this paper
• In vivo reprogramming of adult pancreatic exocrine cells to β-cells

  2008cited by this paper
• Differentiation and characterization of human MSCs.

  2008cited by this paper
• Generation of insulin-secreting cells from pancreatic acinar cells of animal models of type 1 diabetes.

  2007cited by this paper
• Concise Review: Adipose Tissue‐Derived Stromal Cells—Basic and Clinical Implications for Novel Cell‐Based Therapies

  2007cited by this paper
• Comparison of Proliferative and Multilineage Differentiation Potential of Human Mesenchymal Stem Cells Derived from Umbilical Cord and Bone Marrow

  2007cited by this paper
• Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells.

  2007cited by this paper
• Human Umbilical Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's Disease

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells.

  2006cited by this paper
• Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells

  2006cited by this paper
• Induction of Pancreatic Stem/Progenitor Cells into Insulin-Producing Cells by Adenoviral-Mediated Gene Transfer Technology

  2006cited by this paper
• Generation of pancreatic insulin-producing cells from embryonic stem cells — ‘Proof of principle’, but questions still unanswered

  2006cited by this paper
• Human Bone Marrow Mesenchymal Stem Cells Can Express Insulin and Key Transcription Factors of the Endocrine Pancreas Developmental Pathway upon Genetic and/or Microenvironmental Manipulation In Vitro

  2005cited by this paper
• Insulin expressing cells from differentiated embryonic stem cells are not beta cells

  2004cited by this paper
• Mutations in PTF1A cause pancreatic and cerebellar agenesis

  2004cited by this paper
• Transcriptional networks controlling pancreatic development and beta cell function

  2004cited by this paper
• Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells.

  2004influential reference
• Extrapancreatic insulin-producing cells in multiple organs in diabetes.

  2004cited by this paper
• Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes

  2004influential reference
• Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation.

  2004cited by this paper
• In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells

  2004cited by this paper
• β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

  2003cited by this paper
• Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

  2003cited by this paper
• Searching for Alternative Sources of Postnatal Human Mesenchymal Stem Cells: Candidate MSC‐Like Cells from Umbilical Cord

  2003cited by this paper
• The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors

  2002cited by this paper
• Human adipose tissue is a source of multipotent stem cells.

  2002cited by this paper
• Isolation and Characterization of Size‐Sieved Stem Cells from Human Bone Marrow

  2002cited by this paper
• neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas.

  2000cited by this paper
• Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice.

  2000cited by this paper
• In vitro cultivation of human islets from expanded ductal tissue.

  2000cited by this paper
• Embryonic stem cell lines derived from human blastocysts.

  1998cited by this paper
• Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells.

  1998cited by this paper
• A new approach to the induction of duct epithelial hyperplasia and nesidioblastosis by cellophane wrapping of the hamster pancreas.

  1983cited by this paper

• Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial

  2021cites this paper
• Hydrogel nanoparticles covered by neuroligin-2-derived peptide-protected β cells under oxidative stress and increase their proliferation

  2018cites this paper
• In vitro preconditioning of insulin-producing cells with growth factors improves their survival and ability to release insulin

  2018cites this paper
• Stem Cell Therapy: Recent Success and Continuing Progress in Treating Diabetes

  2018cites this paper
• In vitro preconditioning of insulin-producing cells with growth factors improves their survival and ability to release insulin

  2018cites this paper
• OriginalBasicScienceçGeneral The Efficacy of a Prevascularized , Retrievable Poly ( D , L ,-lactide-coe-caprolactone ) Subcutaneous Scaffold as Transplantation Site for Pancreatic Islets

  2017cites this paper
• Mimicking Neuroligin-2 Functions in β-Cells by Functionalized Nanoparticles as a Novel Approach for Antidiabetic Therapy.

  2017cites this paper
• Muscle-derived stem cells in peripheral nerve regeneration: reality or illusion?

  2017cites this paper
• FGF-2b and h-PL Transform Duct and Non-Endocrine Human Pancreatic Cells into Endocrine Insulin Secreting Cells by Modulating Differentiating Genes

  2017cites this paper
• The Efficacy of a Prevascularized, Retrievable Poly(D,L,-lactide-co-ε-caprolactone) Subcutaneous Scaffold as Transplantation Site for Pancreatic Islets

  2017cites this paper
• New Trends in Stem Cell Transplantation in Diabetes Mellitus Type I and Type II

  2017cites this paper
• Microfluidic single-cell transcriptional analysis rationally identifies novel surface marker profiles to enhance cell-based therapies

  2016cites this paper
• Therapeutic Stem Cells Answer a Strategic Breakthrough Need of Healthcare

  2016cites this paper
• A Retrievable, Efficacious Polymeric Scaffold for Subcutaneous Transplantation of Rat Pancreatic Islets

  2016cites this paper
• The bioartificial pancreas (BAP): Biological, chemical and engineering challenges.

  2016cites this paper
• An islet-titration study in a prevascularized, retrievable poly (D,L,-lactide-co-ε-caprolactone) subcutaneous scaffold

  2016cites this paper
• Effects of β-like cell autotransplantation through hepatic arterial intervention on diabetic dogs

  2016cites this paper
• Differentiation Potential of Mouse Embryonic Stem Cells into Insulin Producing Cells in Pancreatic Islet Microenvironment.

  2015cites this paper
• Stem Cells Derived Insulin-Secreting Cells for Insulin-Dependent Diabetes Mellitus: Exploiting Laboratory Discoveries

  2015cites this paper
• Differentiated mesenchymal stem cells ameliorate cardiovascular complications in diabetic rats

  2015cites this paper
• Nieuwe inzichten in therapeutische mogelijkheden bij diabetes mellitus type 1

  2015cites this paper
• Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives.

  2014cites this paper
• Underpinnings of cellular organ replacement therapies.

  2014cites this paper
• Mass Production of Mesenchymal Stem Cells — Impact of Bioreactor Design and Flow Conditions on Proliferation and Differentiation

  2014cites this paper
• General Discussion

  2012cites this paper